Synthesis, isomerization and biological activity of novel 2-selenohydantoin derivatives

[Display omitted] A set of novel selenohydantoins were synthesized via a convenient and versatile approach involving the reaction of isoselenocyanates with various amines. We also revealed an unexpected Z→E isomerization of pyridin-2-yl-substituted selenohydantoins in the presence of Cu2+ cations. T...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2016-02, Vol.24 (4), p.802-811
Hauptverfasser: Ivanenkov, Yan A., Veselov, Mark S., Rezekin, Igor G., Skvortsov, Dmitriy A., Sandulenko, Yuri B., Polyakova, Marina V., Bezrukov, Dmitry S., Vasilevsky, Sergey V., Kukushkin, Maxim E., Moiseeva, Anna A., Finko, Alexander V., Koteliansky, Victor E., Klyachko, Natalia L., Filatova, Lubov A., Beloglazkina, Elena K., Zyk, Nikolay V., Majouga, Alexander G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] A set of novel selenohydantoins were synthesized via a convenient and versatile approach involving the reaction of isoselenocyanates with various amines. We also revealed an unexpected Z→E isomerization of pyridin-2-yl-substituted selenohydantoins in the presence of Cu2+ cations. The detailed mechanism of this transformation was suggested on the basis of quantum-chemical calculations, and the key role of Cu2+ was elucidated. The obtained compounds were subsequently evaluated against a panel of different cancer cell lines. As a result, several molecules were identified as promising micromolar hits with good selectivity index. Instead of analogous thiohydantoins, which have been synthesized previously, selenohydantoins demonstrated a relatively high antioxidant activity comparable (or greater) to the reference molecule, Ebselen, a clinically approved drug candidate. The most active compounds have been selected for further biological trials.
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2015.12.050